// App-Quantinova.ai

: Acitretin Reduces L-Selectin Expression and Tumour Cell Homing in Chronic Lymphocytic Leukaemia (CLL)

Researchers

Presenter

  • Saad Ahmed

Principal Investigators

  • Mattia Cremona

  • Sinead Toomey

  • Mark Catherwood

  • Stephen Bergin

  • Paul Kennedy

  • Bryan Hennessy

  • Patrick Thornton

  • John Quinn

  • Philip Murphy

Medical Centers

  • Molecular Medicine Department, RCSI, Beaumont Hospital, Dublin, Ireland

  • Molecular Medicine Department, RCSI, Beaumont Hospital, Dublin, Ireland

  • Belfast City Hospital, Belfast, United Kingdom

  • Haematology Laboratory, Beaumont Hospital, Dublin, Ireland

  • Beaumont Hospital, Department of Medical Oncology, Royal College of Surgeons in Ireland, Dublin, Ireland

  • Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland

Locations

  • Ireland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • C-X-C motif chemokine receptor 4

  • L-selectin

Drug/Treatment

  • DMSO

  • Acitretine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved